Association for Training, Education, and Research in Hematology, Immunology, and Transplantation
5
0
0
4
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 5 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 4 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (5)
Sequential Conditioning in Haploidentical Transplantation for Hematopoietic Stem Cells in Patients With Relapsed or Refractory Lymphoid Hematological Disorders
Role: lead
Thrombopoietin Agonists in Patients With Idiopathic Thrombocytopenic Purpura
Role: collaborator
Sequential Conditioning in Haploidentical Transplantation for Refractory Acute Myeloid Leukemia
Role: lead
Non-interventional Study on Salvage Auto in Relapsed Myeloma
Role: lead
Non-interventional Study on TEAM Conditioning in Patients With Lymphoma (TEAM)
Role: lead
All 5 trials loaded